Queen Mary University of London
5 days ago
PhD in MCTR3 Signalling in Synovial Inflammation and Tissue Repair Queen Mary University of London in United Kingdom
Degree Level
PhD
Field of study
Immunology
Funding
Fully funded Doctoral Candidate position within HARPNET, a Marie Skłodowska-Curie Actions Doctoral Network. Funding includes an employment contract plus applicable MSCA living and mobility allowances; family allowances may apply where eligible.
Deadline
Oct 1, 2026
Country
United Kingdom
University
Queen Mary University of London
How do I apply for this?
Sign in for free to reveal details, requirements, and source links.
Apply for this position
Keywords
Suggested positions
About this position
PhD opportunity in MCTR3 signalling in synovial inflammation and tissue repair at Queen Mary University of London (William Harvey Research Institute), supervised by Dr J Dalli.
This project investigates how MCTR3 (maresin conjugates in tissue regeneration) activates its receptor and reprogrammes synovial macrophages and fibroblasts in rheumatoid arthritis. The work connects receptor signalling to cellular metabolism, efferocytosis, phosphoproteomic pathways, tissue-specific responses, and repair mechanisms in experimental and human arthritis.
Research training includes GPCR pharmacology, second-messenger analysis, mammalian cell culture, phosphoproteomics, lipidomics, metabolomics, macrophage and fibroblast functional assays, transcriptomics, immunology, and human tissue analysis.
Applicants should have a background in pharmacology, biochemistry, immunology, molecular biology, or cell signalling, plus experience in mammalian cell culture and quantitative laboratory methods. A strong interest in receptor pharmacology is essential. Candidates must hold, or expect to obtain by October 2026, a Master’s degree or equivalent that allows doctoral enrolment at QMUL. The call is open to candidates of any nationality, but MSCA mobility rules apply: applicants must not have lived or carried out their main activity in the UK for more than 12 months in the 36 months before recruitment.
This is a fully funded doctoral candidate position in the HARPNET Marie Skłodowska-Curie Actions Doctoral Network. Funding includes an employment contract and MSCA living and mobility allowances; family allowances may apply where eligible.
To apply, go to the HARPNET recruitment page and submit one central application, ranking up to three project choices. Application queries can be sent to [email protected].
Deadline: 2026-10-01.
Funding details
Fully funded Doctoral Candidate position within HARPNET, a Marie Skłodowska-Curie Actions Doctoral Network. Funding includes an employment contract plus applicable MSCA living and mobility allowances; family allowances may apply where eligible.
What's required
Applicants should have a background in pharmacology, biochemistry, immunology, molecular biology or cell signalling, with experience in mammalian cell culture and quantitative laboratory methods. A strong interest in receptor pharmacology is essential. Candidates must hold, or expect to obtain by October 2026, a Master’s degree or equivalent that permits doctoral enrolment at Queen Mary University of London. Applicants must not already hold a doctoral degree, must be proficient in English, and must satisfy the MSCA mobility rule by not having resided or carried out their principal activity in the United Kingdom for more than 12 months in the 36 months immediately preceding recruitment.
How to apply
Visit the HARPNET recruitment page for full details and submit one central HARPNET application. You may rank up to three project choices. For application queries, contact [email protected].
More information can be found here
Ask ApplyKite AI
How do I apply for this?
Sign in for free to reveal details, requirements, and source links.